The Multiphoton Microscopy Market in 2026 is advancing toward clinical application in dermatology and oncology through the development of clinical-grade multiphoton microscopy systems designed for in vivo or fresh tissue imaging that provide histopathological tissue characterization without excision and processing, addressing the fundamental limitation of current cancer diagnostic workflows that require tissue removal, fixation, sectioning, and staining before microscopic examination that takes hours to days. In vivo multiphoton microscopy of skin uses two-photon autofluorescence from endogenous fluorophores including NADH, FAD, and keratin alongside second-harmonic generation from dermal collagen to provide subcellular resolution imaging of epidermal keratinocyte morphology, the dermoepidermal junction, and upper dermal collagen structure that enables visualization of melanoma and basal cell carcinoma architectural and cytological features resembling histopathological findings in optical sections of intact skin. The JenLab DermaInspect and Caliber Imaging's VivaScope represent commercial clinical multiphoton and reflectance confocal microscopy systems designed for dermatological in vivo imaging that have achieved CE marking in Europe and are used at research dermatology centers for non-invasive diagnosis and monitoring of melanocytic lesions, inflammatory skin conditions, and treatment response assessment. Second-harmonic generation imaging of collagen provides unique quantitative information about collagen fiber organization, crosslinking density, and fibril orientation that characterizes the tumor stroma microenvironment in breast cancer, pancreatic cancer, and other solid tumors where stromal collagen architecture influences cancer progression, metastasis, and drug delivery that cannot be obtained from conventional histopathological staining.

Fluorescence lifetime imaging microscopy integrated with two-photon excitation is providing metabolic characterization of cancer cells through the fluorescence lifetime of NADH and FAD that reflects the relative contributions of oxidative phosphorylation and glycolysis to cellular energy metabolism, enabling optical metabolic imaging that identifies the Warburg effect metabolic phenotype of cancer cells without exogenous metabolic reporters. The combination of SHG collagen imaging with two-photon fluorescence from cellular autofluorescence and from exogenously applied fluorescent probes in multimodal non-linear optical microscopy platforms creates comprehensive tissue characterization that encompasses cellular morphology, metabolic state, and extracellular matrix organization in a single imaging session without tissue processing. Clinical translation of multiphoton microscopy requires development of regulatory-compliant clinical instruments with appropriate laser safety classification, user-safe power levels adequate for clinical imaging performance, standardized imaging protocols with validated tissue characterization algorithms, and training programs enabling clinical dermatologists and pathologists to interpret multiphoton image data within clinical workflow time constraints. As the clinical multiphoton microscopy field continues developing through instrument engineering advances that improve clinical usability, computational tissue analysis tools that automate histopathological feature extraction from multiphoton images, and clinical validation studies demonstrating diagnostic accuracy comparable to conventional histopathology, the technology is expected to progress toward broader clinical deployment in cancer center and dermatology practice settings.

Do you think in vivo multiphoton microscopy of skin will eventually replace punch biopsy as the primary diagnostic approach for evaluating suspicious melanocytic skin lesions in dermatology practice, or will the absolute certainty of histopathological tissue analysis maintain biopsy as the gold standard regardless of optical biopsy advances?

FAQ

• What endogenous tissue fluorophores and non-linear optical contrast mechanisms enable label-free tissue imaging by multiphoton microscopy and what biological information does each provide? Two-photon autofluorescence from NADH excited at approximately seven hundred to seven hundred fifty nanometers reveals cellular metabolic activity in epithelial cells and can identify metabolically active cancer cells through altered NADH concentration and localization, FAD autofluorescence excited at approximately eight hundred to eight hundred fifty nanometers complements NADH imaging for metabolic ratio analysis through the optical redox ratio FAD/NADH that reflects cellular metabolic phenotype, keratin autofluorescence in epithelial cells provides epidermal structural information distinguishing normal from hyperproliferative states, second-harmonic generation from collagen excited at any wavelength generating half-wavelength emission reveals fibrillar collagen organization in dermis and tumor stroma, and third-harmonic generation at interfaces between materials with different refractive indices including lipid water interfaces reveals cellular membrane organization and lipid droplets.
• How is fluorescence lifetime imaging microscopy combined with two-photon excitation for cancer metabolic characterization and what advantages does FLIM provide over intensity-based fluorescence measurements? Two-photon FLIM combines pulsed near-infrared laser excitation with time-correlated single-photon counting detection that measures the decay kinetics of fluorescence emission following each laser pulse, generating pixel-by-pixel fluorescence lifetime maps that reflect the molecular environment of each fluorophore rather than simply its concentration, with NADH fluorescence lifetime distinguishing free NADH in solution at short lifetime of approximately four hundred picoseconds from enzyme-bound NADH at longer lifetimes of one to five nanoseconds depending on the specific dehydrogenase binding partner, enabling quantification of the bound-to-free NADH ratio that reflects the proportion of NADH engaged in oxidative phosphorylation enzyme complexes versus freely diffusing glycolytically produced NADH, identifying the metabolic shift toward glycolysis in cancer cells through their characteristic shorter mean NADH lifetime compared to normal oxidative metabolism cells.

#MultiphotonMicroscopy #ClinicalImaging #Dermatology #FLIM #SecondHarmonicGeneration #OncologyImaging